Get started
Author

Alessandro Pascucci

Observed names: A Pascucci, A. Pascucci
Observed institutions: University of Siena, University of Geneva, Ospedale Santa Maria alle Scotte, University Hospital of Geneva, Azienda Ospedaliera Universitaria Senese, Fondation Pôle Autisme
ORCID: 0009-0002-9740-7415
Observed ORCID: 0009-0002-9740-7415
OpenAlex ID: A5109704430
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients
2006 · P. Correale, D. Cerretani, et al. · Oncology Reports · 56
PDF
Coagulation Factor Levels in Non-Metastatic Colorectal Cancer Patients
2008 · S. Battistelli, M. Stefanoni, et al. · The International Journal of Biological Markers · 40
Oral Metronomic Chemo-Hormonal-Therapy of Metastatic Breast Cancer with Cyclophosphamide and Megestrol Acetate
2010 · A. Licchetta, P. Correale, et al. · Journal of Chemotherapy · 32
PDF
Biweekly Triple Combination Chemotherapy with Gemcitabine, Oxaliplatin, Levofolinic Acid and 5-Fluorouracil (GOLF) Is a Safe and Active Treatment for Patients with Inoperable Pancreatic Cancer
2008 · P. Correale, F. Montagnani, et al. · Journal of Chemotherapy · 15
Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation
2007 · P Correale, A Sciandivasci, et al. · British Journal of Cancer · 14
Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study
2011 · R Petrioli, A Pascucci, et al. · British Journal of Cancer · 13
PDF
Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review
2025 · Alessandro Pascucci, Fabienne Gerber, et al. · Frontiers in Psychiatry · 4
PDF
Effect of neoadjuvant epirubicin and total androgen blockade on complete pathological response in patients with clinical stage T3/T4 prostate cancer
2007 · G. Francini, L. Paolelli, et al. · European Journal of Surgical Oncology · 4
PDF
123P A phase II study of nivolumab (N) plus ipilimumab (I) and ASTX727 or N plus I in PD-1/PD-L1 resistant melanoma or NSCLC patients: The run-in phase of the NIBIT Foundation ML1 study
2023 · A.M. Di Giacomo, G. Rossi, et al. · Immuno-Oncology Technology · 3
PDF
Developmental Alterations in the Diffusion Tensor Imaging Analysis Along the Perivascular Space Index Suggest Possible Glymphatic-Related Mechanisms Underlying Excitation/Inhibition Imbalance and Psychosis Vulnerability in 22q11.2 Deletion Syndrome
2026 · Alessandro Pascucci, Silas Forrer, et al. · Biological Psychiatry Global Open Science · 2
Aberrant cerebrovascular reactivity presents as an early biomarker of psychosis susceptibility in patients with 22q11.2DS
2026 · Farnaz Delavari, Stefano Moia, et al. · Translational Psychiatry · 1
PDF
A diffusion MRI-derived perivascular metric related to glymphatic-associated processes in bipolar disorder vulnerability: Multimodal correlates across emotion dysregulation patients and offspring
2026 · Alessandro Pascucci, Farnaz Delavari, et al. · Psychiatry Research · 1
Transdiagnostic Reductions in Glymphatic-Related Perivascular Diffusion Across Psychiatric Disorders: A Systematic Review and Meta-analysis
2026 · Alessandro Pascucci, Luigi F Saccaro, et al. · medRxiv · 1
PDF
Hypnosis as a Non-Pharmacologic Adjunct in Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Essential Tremor: A Case Report
2025 · Alessandro Pascucci, Alexandre Jeleff, et al. · American Journal of Case Reports · 1
Developmental Glymphatic Dysfunction Underlies Excitation/Inhibition Imbalance and Psychosis Vulnerability in 22q11.2 Deletion Syndrome
2025 · Alessandro Pascucci, Silas Forrer, et al. · medRxiv · 1
PDF
Transdiagnostic reductions in glymphatic-related perivascular diffusion across psychiatric disorders: A systematic review and meta-analysis
2026 · Alessandro Pascucci, Luigi F. Saccaro, et al. · Neuroscience & Biobehavioral Reviews
Linking regional administrative data with an hospital pathology registry in Italy to describe first-line pharmacotherapy of non-resectable non-small cell lung cancer in 2009-2017
2020 · Andrea Spini, Giuseppe Roberto, et al. · Use Siena air (University of Siena)
Nab-paclitaxel plus bevacizumab in heavily pretreated HER2-negative metastatic breast cancer
2015 · S.T. Miano, G. Rossi, et al. · Annals of Oncology
EP-1647: Re-planning of field-in-field tangential treatment based on misalignment during the delivery
2015 · M. Cignitti, D. Gaudino, et al. · Radiotherapy and Oncology
EP-1857: Field-in-Field technique for breast cancer radiotherapy: dosimetric advantages and practical problems
2014 · A. Pascucci, F. Cellini, et al. · Radiotherapy and Oncology
Works count: 18
Citation count: 186
H-index: 6
I10-index: 6
Year
Topic
Type